MedPath

Prevention of Inflammation in Perthes Disease Using Steroid Injections

Recruiting
Conditions
Perthes Disease
Musculoskeletal - Other muscular and skeletal disorders
Registration Number
ACTRN12613000298718
Lead Sponsor
The Children's Hospital at Westmead
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

1.Boys and girls aged 4 years to 12 years old (inclusive)
2.Unilateral Perthes disease diagnosed on x-ray and confirmed on Gadolinium enhanced MRI,
3.No previous operative interventions
4.Less than 20 degrees of abduction in hip extension.

Exclusion Criteria

1.Femoral head AVN not due to Perthes disease.
2.Previous treatment with bisphosphonates.
3.Current pregnancy or sexually active and not using a medically acceptable form of birth control of both male and female participants
4.History of clinically significant organic or psychiatric disease or findings on physical examination, which in the opinion of the Investigator would prevent the patient from completing the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in Range of Movement (ROM). This will be assessed by blinded physiotherapists who will perform all the ROM measurements on all the patients. The blinded physiotherapists will be assessing in degrees with a goniometer: Abduction, Adduction, Internal rotation, External rotation, flexion and fixed flexion deformity. [Week 2, Week 6, Month 3, Month 6, Month 9 and Month 12 compared to screening.]
Secondary Outcome Measures
NameTimeMethod
Radiographs (AP, AP abduction and frog lateral) will be assessed for:<br>- Sphericity<br>- Congruency of the hip<br>- Reduction of Shenton’s line (i.e. measuring subluxation)<br>- Reimer’s migration index and femoral head uncovering<br>- Deformity index. [Month 3, 6, 9 and 12 compared to screening.];Limp assessment scale to assess degree of limping by parents[Week 2, Week 6, Month 3, Month 6, Month 9 and Month 12 compared to screening.];Faces-pain scale[Week 2, Week 6, Month 3, Month 6, Month 9 and Month 12 compared to screening.]
© Copyright 2025. All Rights Reserved by MedPath